|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_ocn891396950 |
| 003 |
OCoLC |
| 005 |
20231120111740.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
140919t20152015caua ob 001 0 eng d |
| 040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d OCLCO
|d YDXCP
|d UIU
|d CUS
|d OCLCF
|d MMU
|d UIU
|d BUF
|d OCLCO
|d OCL
|d OCLCO
|d OPELS
|d LVT
|d Z5A
|d OCLCO
|d MERER
|d OCLCO
|d OCLCQ
|d LEATE
|d OCLCA
|d OCLCQ
|d U3W
|d D6H
|d OCLCQ
|d NAM
|d ESEHU
|d FQM
|d AU@
|d OCLCO
|d OCLCQ
|d DEBBG
|d OCLCQ
|d DCT
|d ERF
|d RDF
|d UHL
|d ESU
|d GWM
|d AUD
|d ZCU
|d UAB
|d VLY
|d LUN
|d N9V
|d YBX
|d S2H
|d OCLCO
|d REDDC
|d TUHNV
|d OCLCA
|d SFB
|d CASUM
|d OCLCO
|d COM
|d OCLCQ
|d OCLCO
|
| 066 |
|
|
|c (S
|
| 020 |
|
|
|a 9780124167285
|q (e-book)
|
| 020 |
|
|
|a 0124167284
|q (e-book)
|
| 020 |
|
|
|z 9780124167216
|q (print)
|
| 020 |
|
|
|z 0124167217
|q (print)
|
| 035 |
|
|
|a (OCoLC)891396950
|
| 050 |
|
4 |
|a RC280.B6
|
| 060 |
|
4 |
|a WE 258
|
| 082 |
0 |
4 |
|a 616.99471
|2 23
|
| 245 |
0 |
0 |
|a Bone cancer :
|b primary bone cancers and bone metastases /
|c edited by Dominique Heymann.
|
| 250 |
|
|
|a Second edition.
|
| 264 |
|
1 |
|a San Diego, California ;
|a Waltham, Massachusetts :
|b Elsevier/Academic Press,
|c 2015.
|
| 264 |
|
4 |
|c �2015
|
| 300 |
|
|
|a 1 online resource (730 pages) :
|b illustrations (some color)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a "Elsevier science & technology books."
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|6 880-01
|a Epidemiology of primary bone tumors and economical aspects of bone metastases -- Tumor: bone interactions: there is no place like bone -- Stem cell niches in the bone: bone marrow organ and their significance for hematopoietic and non-hematopoietic cancer -- Deregulation of osteoblast differentiation in primary bone cancers -- Contribution of osteoclasts to the bone: tumor niche -- Involvement of osteocytes in cancer bone niche -- Role of mesenchymal stem cells in bone cancer; initiation, propagation and metastasis -- Gap junction in bone remodeling and in primary bone tumors: osteosarcoma and Ewing sarcoma -- Macrophages and pathophysiology of bone cancers -- Cytokines and bone cancers -- Technical aspects: how do we best prepare bone samples for proper histological analysis? -- Bone remodeling markers and bone cancer -- Cancer stem cells in representative bone tumors: osteosarcoma, Ewing sarcoma and metastases from breast and prostate carcinomas -- Homeobox genes from the Dlx family and bone cancers -- MicroRNA implication in therapeutic resistance and metastatic dissemination of bone-associated tumors -- Hypoxia and angiogenesis: from primary tumor to bone metastasis -- Modeling osteosarcoma: in vitro and in vivo approaches -- Stemness markers of osteosarcoma -- Molecular pathology of osteosarcoma -- Gene and proteomic profiling of osteosarcoma -- Ewing sarcoma family of tumors -- Biology of Ewing sarcoma -- Osteoclast-rich lesions of bone: a clinical and molecular overview -- Markers for bone sarcomas -- Margins and bone tumors: what are we talking about? -- Cytogenetics of bone tumors -- Genetic aspects of bone tumors -- Cytogenetic and molecular genetic alterations in bone tumors -- Genetics of giant cell tumors of bone -- Mammalian models of bone sarcomas -- Zebrafish models for studying bone cancers: mutants, transgenic fish and embryos -- Imaging of bone sarcomas -- New therapeutic targets in Ewing sarcoma: from pre-clinical proof-of-concept to clinical trials -- Therapeutic approaches for bone sarcomas -- Chondrosarcoma of bone: diagnosis and therapy -- Apoptosis and drug resistance in malignant bone tumors -- Giant cell tumors of bone -- EMT process in bone metastasis -- Histopathology of skeletal metastases -- Disseminated tumor cells in bone marrow of cancer patients.
|
| 505 |
0 |
|
|a MicroRNA-mediated regulation of bone metastasis formation: from primary tumors to skeleton -- Myeloma and osteoclast relationship -- In vivo models used in studies of bone metastases -- Interventional radiologic techniques in management of bone tumors -- Diagnosis of bone metastases in urological malignancies : an update -- Pre-clinical molecular imaging of "the seed and the soil" in bone metastasis -- Mechanisms and management of bone cancer pain -- Bone cancer: current opinion in palliative care -- Involvement of sympathetic nerves in bone metastasis -- Pain control with palliative radiotherapy in patients with bone metastases -- Cellular and molecular actions of bisphosphonates -- The use of nitrogen-bisphosphonates to capture the potent anti-tumor arsenal of human peripheral blood [gamma delta] T cells for the treatment of bone cancer metastasis -- Systemic treatment of bone metastases in castration-resistant prostate cancer (CRPC): pre-clinical to clinical point of view -- A multi-targeted approach to treating bone metastases -- Bone metastases in prostate cancer: pathophysiology, clinical complications, actual treatment, and future directions -- Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases -- Bone metastases : current status of bone-targeted treatments -- Bone metastases, clinical trials II: zoledronic acid and denosumab in the prevention of bone metastases.
|
| 588 |
0 |
|
|a Online resource; title from electronic title page (ClinicalKey, viewed on April 14, 2015).
|
| 650 |
|
0 |
|a Bones
|x Cancer.
|
| 650 |
|
0 |
|a Bone metastasis.
|
| 650 |
|
0 |
|a Bones
|x Cancer
|x Treatment.
|
| 650 |
1 |
2 |
|a Bone Neoplasms
|0 (DNLM)D001859
|
| 650 |
|
6 |
|a Os
|x Cancer.
|0 (CaQQLa)201-0011243
|
| 650 |
|
6 |
|a M�etastases osseuses.
|0 (CaQQLa)201-0213435
|
| 650 |
|
6 |
|a Os
|0 (CaQQLa)201-0011243
|x Cancer
|0 (CaQQLa)201-0011243
|x Traitement.
|0 (CaQQLa)201-0377521
|
| 650 |
|
7 |
|a Bones
|x Cancer
|x Treatment
|2 fast
|0 (OCoLC)fst01767146
|
| 650 |
|
7 |
|a Bone metastasis
|2 fast
|0 (OCoLC)fst00835963
|
| 650 |
|
7 |
|a Bones
|x Cancer
|2 fast
|0 (OCoLC)fst00836000
|
| 655 |
|
4 |
|a Internet Resources.
|
| 700 |
1 |
|
|a Heymann, Dominique,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Bone cancer.
|b Second edition.
|d San Diego, CA : Academic Press, [2015]
|z 9780124167216
|w (OCoLC)890675777
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780124167216
|z Texto completo
|
| 880 |
0 |
|
|6 505-01/(S
|a Contents note continued: 50. Pain control with palliative radiotherapy in patients with bone metastases / Edward Chow -- New therapeutic approaches -- 51. Cellular and molecular actions of bisphosphonates / Michael J. Rogers -- 52. The use of nitrogen-bisphosphonates to capture the potent anti-tumor arsenal of human peripheral blood λδ T cells for the treatment of bone cancer metastasis / Dieter Kabelitz -- 53. Systemic treatment of bone metastases in castration-resistant prostate cancer (CRPC): pre-clinical to clinical point of view / Francois Lamoureux -- 54.A multitargeted approach to treating bone metastases / Kenneth J. Pienta -- 55. Bone metastases in prostate cancer: pathophysiology, clinical complications, actual treatment, and future directions / Dominik R. Berthold -- 56. Bone-targeted agents and skeletal-related events in breast cancer patients with hone metastases / Alexander H.G. Paterson
|
